RCKT logo

Rocket Pharmaceuticals (RCKT) Long Term Debt

Annual Long Term Debt

$22.33 M
+$1.97 M+9.67%

December 31, 2023


Summary


Performance

RCKT Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRCKTbalance sheetmetrics:

Quarterly Long Term Debt

$22.80 M
-$144.00 K-0.63%

September 30, 2024


Summary


Performance

RCKT Quarterly Long Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRCKTbalance sheetmetrics:

Long Term Debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

RCKT Long Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+9.7%+2.1%
3 y3 years-59.1%+2.1%
5 y5 years-46.1%+2.1%

RCKT Long Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+11.4%-1.2%+15.5%
5 y5-year-59.1%+11.4%-65.4%+15.5%
alltimeall time-59.1%+775.5%-65.4%+793.9%

Rocket Pharmaceuticals Long Term Debt History

DateAnnualQuarterly
Sep 2024
-
$22.80 M(-0.6%)
Jun 2024
-
$22.94 M(-0.6%)
Mar 2024
-
$23.08 M(+3.4%)
Dec 2023
$22.33 M(+9.7%)
$22.33 M(-0.0%)
Sep 2023
-
$22.33 M(-0.3%)
Jun 2023
-
$22.39 M(-1.8%)
Mar 2023
-
$22.80 M(+12.0%)
Dec 2022
$20.36 M(+1.5%)
$20.36 M(+3.2%)
Sep 2022
-
$19.73 M(-0.4%)
Jun 2022
-
$19.82 M(-0.4%)
Mar 2022
-
$19.89 M(-0.8%)
Dec 2021
$20.05 M(-63.2%)
$20.05 M(+0.2%)
Sep 2021
-
$20.00 M(-0.8%)
Jun 2021
-
$20.17 M(-63.9%)
Mar 2021
-
$55.87 M(+2.4%)
Dec 2020
$54.55 M(+17.3%)
$54.55 M(-11.6%)
Sep 2020
-
$61.68 M(-6.3%)
Jun 2020
-
$65.83 M(+0.4%)
Mar 2020
-
$65.56 M(+41.0%)
DateAnnualQuarterly
Dec 2019
$46.49 M(+12.2%)
$46.49 M(+1.5%)
Sep 2019
-
$45.79 M(+1.5%)
Jun 2019
-
$45.11 M(+1.5%)
Mar 2019
-
$44.47 M(+7.3%)
Dec 2018
$41.45 M(-16.3%)
$41.45 M(+2.0%)
Sep 2018
-
$40.63 M(+2.0%)
Jun 2018
-
$39.84 M(+1.9%)
Mar 2018
-
$39.08 M(-21.1%)
Dec 2017
$49.54 M(+1.2%)
$49.54 M(+0.3%)
Sep 2017
-
$49.39 M(+0.3%)
Jun 2017
-
$49.24 M(+0.3%)
Mar 2017
-
$49.10 M(+0.3%)
Dec 2016
$48.96 M(+1820.0%)
$48.96 M(+0.3%)
Sep 2016
-
$48.82 M(+446.9%)
Jun 2015
-
$8.93 M(+3.0%)
Mar 2015
-
$8.67 M(+239.9%)
Dec 2014
$2.55 M(-52.7%)
$2.55 M(-22.6%)
Sep 2014
-
$3.29 M(-38.9%)
Dec 2013
$5.39 M
$5.39 M

FAQ

  • What is Rocket Pharmaceuticals annual long term debt?
  • What is the all time high annual long term debt for Rocket Pharmaceuticals?
  • What is Rocket Pharmaceuticals annual long term debt year-on-year change?
  • What is Rocket Pharmaceuticals quarterly long term debt?
  • What is the all time high quarterly long term debt for Rocket Pharmaceuticals?
  • What is Rocket Pharmaceuticals quarterly long term debt year-on-year change?

What is Rocket Pharmaceuticals annual long term debt?

The current annual long term debt of RCKT is $22.33 M

What is the all time high annual long term debt for Rocket Pharmaceuticals?

Rocket Pharmaceuticals all-time high annual long term debt is $54.55 M

What is Rocket Pharmaceuticals annual long term debt year-on-year change?

Over the past year, RCKT annual long term debt has changed by +$1.97 M (+9.67%)

What is Rocket Pharmaceuticals quarterly long term debt?

The current quarterly long term debt of RCKT is $22.80 M

What is the all time high quarterly long term debt for Rocket Pharmaceuticals?

Rocket Pharmaceuticals all-time high quarterly long term debt is $65.83 M

What is Rocket Pharmaceuticals quarterly long term debt year-on-year change?

Over the past year, RCKT quarterly long term debt has changed by +$464.00 K (+2.08%)